Funding: Naloxone

Provides funding to address immediate and short-term needs for substance use disorder (SUD) services in rural communities. Aims to establish or expand SUD prevention, harm reduction, treatment, and recovery services, with the goal of reducing and preventing overdoses in rural areas.

Awards funding for pilot projects to establish portable clinical care teams that provide healthcare outside for underserved populations experiencing unsheltered homelessness. Promotes syndemic approaches that successfully integrate behavioral health and HIV treatment and prevention, including low barrier substance use disorder (SUD) treatment; HIV and viral hepatitis testing and treatment; HIV prevention including condom, Pre-Exposure Prophylaxis (PrEP) and Post-Exposure Prophylaxis (PEP) distribution; mental healthcare; and harm reduction services.

Offers formula grants to states to help develop and expand prevention, harm reduction, treatment, and recovery activities for opioid use disorder (OUD) and stimulant use. Seeks to improve the accessibility and effectiveness of treatment and services for individuals with OUD, including access to Food and Drug Administration (FDA)-approved medications for the treatment of OUD.

Helps American Indian and Alaska Native (AI/AN) tribal communities build and strengthen a comprehensive response to the opioid epidemic by providing prevention, harm reduction, treatment, and community-based recovery support services to AI/AN individuals with, or at risk for, opioid use disorder (OUD), including stimulant use disorder. Identifies and addresses gaps in services and systems of care for OUD in tribal communities, and coordinates with other federally supported opioid response efforts to increase access to innovative and culturally responsive services for people with OUD, including access to Food and Drug Administration (FDA)-approved medications for the treatment of opioid use disorder (MOUD).

Provides funding for training and resources to first responders and members of other key community sectors at the state, tribal, and local levels on carrying and administering naloxone and other Food and Drug Administration approved drugs or devices for emergency reversal of known or suspected opioid overdose. Works to establish processes and protocols for referral to appropriate treatment recovery, harm reduction, and other psychosocial support services, and provide safety education around fentanyl, synthetic opioids, and other drug trends associated with overdoses.

Offers funding to recruit and train emergency medical services (EMS) personnel in rural areas with a primary focus on addressing substance use disorders (SUDs) and co-occurring mental health conditions (COD). Supports training on trauma-informed, recovery-based SUD/COD emergency care for rural residents, including the use of naloxone for the reversal of opioid overdose, and helps EMS staff meet federal or state licensing or certification requirements.

Supports efforts to address the opioid crisis in American Indian and Alaska Native (AI/AN) communities through locally designed prevention, treatment, recovery, and aftercare services for mental health and substance use disorder (SUD). Aims to raise awareness and education of opioid interventions that are family-centered and culturally appropriate, create comprehensive community opioid support teams, and increase the use of medication-assisted treatment (MAT)/medications for opioid use disorder (MOUD) to meet treatment needs and reduce opioid overdose in AI/AN communities. COIPP is an initiative of IHS's Alcohol and Substance Abuse Branch (ASAB).

Provides peer recovery support services to individuals with or in recovery from substance use disorder (SUD) or co-occurring substance use and mental disorders (COD). Promotes long-term recovery supports, in coordination with clinical SUD treatment, that are led by peers in recovery who reflect the communities they serve. Increases access to recovery support services through training and support for current and new peer recovery specialists and supervisors, especially those from historically underserved communities.

Provides funding to enhance the ability of state health departments to track and prevent nonfatal and fatal overdoses and identify emerging drug threats by supporting surveillance and prevention strategies designed to reduce overdose morbidity and mortality. Emphasizes activities focused on opioid, stimulants, and polysubstance use and works to address health inequities and increase access to care and services for populations at high-risk for overdose, including rural communities and tribal populations.

Provides funding for local health departments, special district health departments, and territorial governments to implement data-based surveillance and prevention strategies to reduce overdose morbidity and mortality in communities. Emphasizes activities focused on opioids and stimulants. Seeks to address health inequities and increase access to care for populations at high-risk for overdose, including rural communities and tribal populations.

Funds treatment, recovery, case management, and harm reduction services and programs in residential treatment facilities for pregnant and postpartum women with substance use disorder (SUD) to support and sustain recovery. Aims to reduce infant and maternal mortality; improve family dynamics through access to treatment; and increase access to evidence-based SUD residential services.

Expands access at the community level to naloxone and other medications approved by the Food and Drug Administration (FDA) for emergency treatment of opioid overdose by establishing best practices for prescribing overdose reversal drugs. Provides training and resources to prescribers and providers and ensures protocols are in place to connect people who have experienced overdose to appropriate follow-up care and substance use treatment, including medications for opioid use disorder (MOUD) and behavioral therapies. Focuses on specific urban and rural populations to address the needs and expand workforce capacity in communities highly impacted by overdose and reduce overdose deaths.